erlotinib hydrochloride has been researched along with Skin Abnormalities in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, K; Fujino, H; Kagawa, Y; Kamiya, D; Kimura, M; Miyazaki, Y; Mizuno, H; Moriki, M; Sano, Y; Shirai, T; Suzuki, T; Todoroki, K; Uchino, T; Yagi, H | 1 |
1 other study(ies) available for erlotinib hydrochloride and Skin Abnormalities
| Article | Year |
|---|---|
Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lipids; Lung Neoplasms; Prognosis; Skin Abnormalities | 2020 |